This webinar will feature a panel of clinical experts in bone discussing timely topics related to osteoporosis treatment and the COVID-19 pandemic, including:

• Prolia® (denosumab) and the immune system

• Approaches to transitioning patients from Prolia® (denosumab)

• Timing of Evenity® (romosozumab) and possible transition to other treatments

• Transition from skeletal anabolics to antiresorptives

The panel will also be fielding questions from participants. Please click here for more information on the webinar, speakers and registration.